GLP-1 Weight Loss Treatment in Malta: What It Is, Who It's For, and What to Realistically Expect

If you have been following health news over the past two years, you have almost certainly heard about GLP-1 medications — semaglutide, liraglutide, the brand names Ozempic and Wegovy. What started as a treatment for type 2 diabetes has become one of the most significant developments in medical weight management in decades. In Malta, interest in GLP-1 treatment has grown considerably, and with it, a great deal of confusion about what these medications actually are, who they are genuinely appropriate for, and what responsible, medically supervised treatment looks like.

This guide gives you honest, evidence-based answers.

Weight Loss Consultations

What GLP-1 Medications Are

GLP-1 stands for glucagon-like peptide-1 — a hormone your body naturally produces in the gut after eating. It plays several roles: stimulating insulin release, suppressing glucagon (which raises blood sugar), slowing gastric emptying, and — crucially — signalling to the brain that you are full.

GLP-1 receptor agonists are medications that mimic this hormone, amplifying these effects. The result is a meaningful reduction in appetite, slower digestion, improved blood sugar regulation, and a reduced drive to eat — particularly to overeat. The most well-studied GLP-1 medication for weight management is semaglutide, which is available in both injectable and oral forms.

These are prescription medicines. They are not supplements. They are not available over the counter. And the difference between taking them with proper medical oversight and obtaining them through unregulated channels is not a small one — it is the difference between a treatment and a risk.

What the Evidence Actually Shows

The clinical evidence for GLP-1 medications in weight management is substantial and genuinely impressive by the standards of medical research.

The STEP trials — the largest clinical programme studying semaglutide for weight management — found that participants using semaglutide alongside lifestyle support lost an average of 15 per cent of their body weight over 68 weeks, compared to around 2 per cent in the placebo group. Some participants lost significantly more. These are not marginal results. For people who have struggled with their weight for years despite sustained effort, the magnitude of effect is meaningful.

What the trials also show — and what responsible practitioners always communicate — is that GLP-1 medications work best alongside changes in eating patterns and physical activity. They are not a passive treatment. They reduce hunger and improve appetite regulation, which makes behaviour change significantly easier. But the behaviour change still matters.

Who GLP-1 Treatment Is Appropriate For

GLP-1 medications for weight management are clinically indicated for adults who meet specific criteria. These typically include:

• A BMI of 30 or above (classified as obese), or

• A BMI of 27 or above (classified as overweight) with at least one weight-related health condition — such as type 2 diabetes, hypertension, high cholesterol, or sleep apnoea

• Have not achieved adequate results with diet and lifestyle changes alone

• Have no contraindications — including personal or family history of medullary thyroid carcinoma, pancreatitis, or certain other conditions

GLP-1 medications are not appropriate for people who are looking for a quick result with minimal engagement, people who are a few kilograms above their preferred weight, people who are pregnant or breastfeeding, or people who meet the BMI criteria but have unmanaged health conditions that require assessment first.

At Carisma Slimming, our medical team assesses every patient individually. The starting point is always an honest conversation about whether this treatment is the right approach for your specific situation — not whether you would like to try it.

What Medical Supervision Actually Means

This is worth spending time on, because the phrase "medically supervised" is used loosely by a number of providers in Malta and online.

Genuine medical supervision for GLP-1 treatment means:

• A proper assessment before prescribing. Blood tests, blood pressure, full medical history, current medications, BMI and body composition — all reviewed by a doctor before a prescription is issued. Not a checkbox questionnaire on a website.

• A dose titration schedule. GLP-1 medications are started at a low dose and increased gradually over weeks to months. This is not optional — it is how side effects are managed and how the body adjusts. Providers who start at a high dose or skip titration are not managing your care properly.

• Regular monitoring. Weight, blood pressure, blood markers, side effect management — these should be reviewed throughout your treatment, not just at the start.

• Honest conversations about side effects. Nausea is common, particularly in the early weeks. Some people experience vomiting, diarrhoea, or constipation. Fatigue is reported. Rare but serious risks — pancreatitis, gallbladder issues — require monitoring. A responsible provider explains all of this before you start.

• A plan for what comes next. GLP-1 medications are not a permanent solution for most people. What happens when you stop? How do you maintain your results? A good medical team plans for this from the beginning.

The Malta Context: Why This Matters Here

Malta has a higher-than-average rate of obesity and obesity-related conditions compared to many EU member states. The combination of a rich food culture, a relatively sedentary working environment, and limited green space compared to larger countries creates conditions where weight management is genuinely challenging — not a matter of willpower or effort, but of biology and environment.

GLP-1 medications, in the right hands and for the right patients, offer something that has not previously been available in medical weight management: a meaningful reduction in the biological drive to overeat. For Maltese women and men who have tried and tried again — who have followed every piece of advice and still found themselves back where they started — this is a significant development.

It is also a development that deserves to be handled carefully and responsibly, which is why the medical oversight piece matters so much.

"I had been trying to lose weight for twelve years. I tried everything — and I mean everything. My doctor at Carisma was the first person who explained that my difficulty was partly biological, not just about effort. Six months into the programme I have lost 14 kilograms and for the first time I do not feel like I am fighting myself every single day." — Teresa from Birkirkara

What to Ask Before Starting GLP-1 Treatment in Malta

If you are considering GLP-1 treatment, here are the questions worth asking any provider:

• Will a doctor assess me before prescribing?

• What blood tests and health checks are included?

• What dose titration schedule do you follow?

• How often will I be monitored during treatment?

• What support is available if I experience side effects?

• What is the plan for maintaining results after treatment ends?

• What is the total cost including all monitoring appointments?

If any of these questions are met with vague answers, or if the process feels more like purchasing a product than receiving medical care, look elsewhere.

GLP-1 Weight Management at Carisma Slimming

At Carisma Slimming, our GLP-1 weight management programme is led by our doctor — a physician with over 30 years of clinical experience — and includes a full medical assessment before prescribing, body composition analysis using Tanita scales, structured dose titration, regular monitoring appointments, nutritional guidance, and a long-term maintenance plan.

We do not prescribe to everyone who asks. We prescribe to the patients for whom the evidence supports treatment and for whom we can provide the level of oversight the treatment requires.

If you would like to understand whether GLP-1 treatment is appropriate for you, book a consultation at Carisma Slimming. The conversation is honest, the assessment is thorough, and there is no pressure to proceed. Visit carismaslimming.com or call +356 2780 2062.